Related Experiment Video
Updated: Apr 28, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Risk prediction model for cognitive frailty in older adults with diabetes: a systematic review and meta-analysis
Yongyuan Luo1, Heng Duan1, Tingyu Yang1
1College of Nursing, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Objective:
Cognitive frailty (CF) represents a significant geriatric issue closely linked to diabetes. Although multiple CF risk prediction models exist for older adults with diabetes, their methodological quality and clinical utility remain unclear. This systematic review evaluates the predictive performance and risk of bias of existing models to provide inform clinical practice.
Methods:
A systematic search was conducted in PubMed, Embase, Web of Science, Cochrane Library, CINAHL, Sinomed, CNKI, and Wanfang from inception to September 2025. Two researchers independently performed literature screening, data extraction, and quality assessment. Study and model characteristics were summarized descriptively; pooled AUC values were analyzed using Stata 17.0. PROBAST was used to evaluate risk of bias and applicability.
Results:
Eight studies involving 2,947 diabetic patients were included. CF prevalence ranged from 12.1% to 40.0%. Predictors encompassed sociodemographic, disease-related, psychological, and lifestyle factors, with age, depression, diabetes duration, nutritional status, and regular exercise being most frequently reported. The models showed good discrimination (AUC: 0.790-0.975) but exhibited high overall bias risk.
Conclusion:
Existing CF prediction models demonstrate acceptable discrimination but are limited by high bias risk and poor applicability. Future research should prioritize developing rigorously designed models with multicenter external validation to enhance prediction accuracy. The study was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines (17). The study protocol was registered on PROSPERO (CRD420251054250).
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/view/CRD420251054250, identifier CRD420251054250.
Related Concept Videos
Alzheimer Disease l: Introduction
Dementia l: Introduction
Cognitive Development During Adulthood
Drug Dosing: Geriatric Patients
Psychoneuroimmunology: Diabetes and Cancer

